Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients

ClinicalTrials.gov ID: NCT00000655

Public ClinicalTrials.gov record NCT00000655. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 5:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind Study of 566C80 Versus Septra (Trimethoprim/Sulfamethoxazole) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the effectiveness of atovaquone (566C80) compared to a standard antipneumocystis agent, (SMX/TMP), for the treatment of mild to moderate Pneumocystis carinii pneumonia (PCP) in AIDS patients. To compare the safety of short-term (21 days) treatment with 566C80 and SMX/TMP in AIDS patients with an acute episode of PCP. Standard therapies for acute treatment of PCP involve either SMX/TMP or pentamidine isetionate. Although both treatments are equally effective, side effects prevent completion of therapy in 11-55 percent of patients.

Study identification

NCT ID
NCT00000655
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
300 participants

Conditions and interventions

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Jan 1992 (Actual)
Completion
Not listed
Last update posted
Mar 1, 2011

United States locations

U.S. sites
27
U.S. states
13
U.S. cities
18
Facility City State ZIP Site status
Univ of Alabama at Birmingham Birmingham Alabama 35294 —
Kaiser Foundation Hosp Harbor City California 90710 —
USC Los Angeles California 90033 —
Dr Richard Meyer Los Angeles California 90048 —
UCLA CARE Ctr Los Angeles California 90095 —
Infectious Disease Med Group Oakland California 94609 —
Univ of California / San Diego Treatment Ctr San Diego California 921036325 —
San Francisco Gen Hosp San Francisco California 941102859 —
UCSF - San Francisco Gen Hosp San Francisco California 94110 —
Dr Marcus Conant San Francisco California 94115 —
Georgetown Univ Med Ctr Washington D.C. District of Columbia 20007 —
Veterans Administration Med Ctr Washington D.C. District of Columbia 20422 —
Dr Winkler Weinberg Roswell Georgia 30076 —
Johns Hopkins Univ School of Medicine Baltimore Maryland 21205 —
Natl Inst of Allergy & Infect Dis / Cln Ctr Bethesda Maryland 20892 —
Washington Univ School of Medicine St Louis Missouri 63108 —
Beth Israel Med Ctr / Peter Krueger Clinic New York New York 10003 —
Saint Vincent's Hosp and Med Ctr New York New York 10011 —
Harlem AIDS Treatment Group / Harlem Hosp Ctr New York New York 10037 —
Duke Univ Med Ctr Durham North Carolina 27710 —
Univ of Cincinnati Cincinnati Ohio 452670405 —
Good Samaritan Hosp Portland Oregon 972103079 —
Buckley Braffman Stern Med Associates Philadelphia Pennsylvania 19107 —
Regional Med Ctr at Memphis Memphis Tennessee 38103 —
The Regional Medical Ctr, Memphis Memphis Tennessee 38105 —
Plaza Med Ctr Houston Texas 77004 —
Baylor College of Medicine Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000655, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 1, 2011 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00000655 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →